Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC438

Deucravacitinib eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    23.8.2023
  • Application published:
    15.9.2023
  • Grant published:
    15.7.2025
  • Max expiry date:
    26.3.2038
  • Medicine name:
    SOTYKTU
  • Medicine for children:
    No

Timeline

Today
23.8.2023Application
15.9.2023Publication
15.7.2025Registration
26.3.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1718/001-008
  • Date:
    21.4.2023
  • Foreign authorization number:
    EU/1/23/1718
  • Date:
    24.3.2023

Owner

  • Name:
    Bristol-Myers Squibb Company
  • Address:
    Route 206 and Province Line Road, Princeton US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 18.07.2025

Upload documents